MedPath

se of continuous glucose monitoring devices among people living with type 1 diabetes in South Africa

Not Applicable
Conditions
Nutritional, Metabolic, Endocrine
Registration Number
PACTR202310817339585
Lead Sponsor
Foundation for Innovative New Diagnostics
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
246
Inclusion Criteria

Recipients of Care eligibility criteria:
People living with type 1 diabetes with current HbA1c levels =10% / >86mmol/mol (and for at least 2 measurements over 18 months) attending for diabetes care at the 3 sites.
Health care providers eligibility criteria:
Healthcare providers at the study sites engaged in diabetes care provision related to the study

Exclusion Criteria

Recipients of Care exclusion criteria:
•People living with type 1 diabetes under 4 years of age.
•People diagnosed with type 1 diabetes within the last 2 years.
•People who have used a CGM in the last 6 months prior to enrollment.
•People who anticipate that they would have access to a CGM through means outside this study during the duration of the study (15 months).
•People living with type 2 diabetes.
•Known pregnancy at time of enrolment.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.Comparison of the magnitude of change in HbA1c levels (expressed as a percentage and in mmol/mol) before and after treatment in standard of care, continuous and intermittent CGM arms
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath